Tuulia Vallius, Ph.D., M.D.
This page shows the publications Tuulia Vallius has written about CA-125 Antigen.
Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer. Tumour Biol. 2014 Dec; 35(12):12389-95.
Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancer. Tumour Biol. 2017 Feb; 39(2):1010428317691189.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.